{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:47:03Z","timestamp":1792446423542,"version":"4.5.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2013,1,1]]},"DOI":"10.1001\/2013.jamadermatol.39","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T18:35:14Z","timestamp":1358361314000},"page":"23","source":"Crossref","is-referenced-by-count":20,"title":["Intralesional Adalimumab for the Treatment of Refractory Balanitis Xerotica Obliterans"],"prefix":"10.1001","volume":"149","author":[{"given":"Elie B.","family":"Lowenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Zeichner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/1557751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T22:13:46Z","timestamp":1481926426000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/2013.jamadermatol.39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/2013.jamadermatol.39","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,1]]}}}